- Home
- INMB vs VIVO Comparison
INMB vs VIVO Comparison
Compare INMB & VIVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.37
Company Overview
Basic Information| Metric | INMB | VIVO |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 37.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | INMB | VIVO |
|---|---|---|
| Price | $1.37 | $3.41 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.40 | N/A |
| AVG Volume (30 Days) | 289.9K | ★ 636.3K |
| Earning Date | 05-07-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.85 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $1.97 |
| 52 Week High | $11.64 | $3.70 |
Technical Indicators
Market Signals| Indicator | INMB | VIVO |
|---|---|---|
| Relative Strength Index (RSI) | 54.42 | 64.86 |
| Support Level | $1.15 | $1.97 |
| Resistance Level | $1.48 | $3.50 |
| Average True Range (ATR) | 0.09 | 0.38 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 65.67 | 60.14 |
Price Performance
Historical Comparison INMB
VIVO
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.